IGMS
Price
$7.04
Change
-$0.44 (-5.88%)
Updated
Dec 18, 04:11 PM (EDT)
99 days until earnings call
SONN
Price
$1.67
Change
-$0.05 (-2.91%)
Updated
Dec 18, 04:30 PM (EDT)
Ad is loading...

IGMS vs SONN

Header iconIGMS vs SONN Comparison
Open Charts IGMS vs SONNBanner chart's image
IGM Biosciences
Price$7.04
Change-$0.44 (-5.88%)
Volume$100
CapitalizationN/A
Sonnet BioTherapeutics Holdings
Price$1.67
Change-$0.05 (-2.91%)
Volume$150
CapitalizationN/A
IGMS vs SONN Comparison Chart
Loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGMS vs. SONN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMS is a Hold and SONN is a StrongSell.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (IGMS: $7.48 vs. SONN: $1.72)
Brand notoriety: IGMS and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGMS: 66% vs. SONN: 14%
Market capitalization -- IGMS: $444.79M vs. SONN: $4.63M
IGMS [@Biotechnology] is valued at $444.79M. SONN’s [@Biotechnology] market capitalization is $4.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGMS’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 1 green FA rating(s).

  • IGMS’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 1 green, 4 red.
According to our system of comparison, SONN is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGMS’s TA Score shows that 4 TA indicator(s) are bullish while SONN’s TA Score has 4 bullish TA indicator(s).

  • IGMS’s TA Score: 4 bullish, 5 bearish.
  • SONN’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SONN is a better buy in the short-term than IGMS.

Price Growth

IGMS (@Biotechnology) experienced а -21.18% price change this week, while SONN (@Biotechnology) price change was -13.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

IGMS is expected to report earnings on Mar 27, 2025.

SONN is expected to report earnings on Nov 29, 2023.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IGMS($445M) has a higher market cap than SONN($4.63M). IGMS YTD gains are higher at: -9.988 vs. SONN (-87.644). IGMS has more cash in the bank: 219M vs. SONN (3.55M). SONN has less debt than IGMS: SONN (150K) vs IGMS (45.9M).
IGMSSONNIGMS / SONN
Capitalization445M4.63M9,615%
EBITDA-225.78MN/A-
Gain YTD-9.988-87.64411%
P/E RatioN/A0.29-
Revenue2.92MN/A-
Total Cash219M3.55M6,162%
Total Debt45.9M150K30,600%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IGMSSONN
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARRBX15.28N/A
N/A
Aristotle Small Cap Eq R6
EMQCX7.82N/A
N/A
Ashmore Emerging Markets Active Eq C
USRAX33.62-0.11
-0.33%
Horizon Multi-Factor U.S. Equity Inv
JGIRX87.14-0.31
-0.35%
JPMorgan U.S. GARP Equity R5
FTHCX96.54-0.62
-0.64%
Fidelity Advisor Technology C

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MDGL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+1.08%
MDGL - IGMS
42%
Loosely correlated
-1.58%
ABCL - IGMS
38%
Loosely correlated
-2.45%
FATE - IGMS
38%
Loosely correlated
-6.00%
BTAI - IGMS
37%
Loosely correlated
-4.01%
GBIO - IGMS
37%
Loosely correlated
-6.03%
More

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and DWTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and DWTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-4.97%
DWTX - SONN
27%
Poorly correlated
-4.49%
PHAR - SONN
25%
Poorly correlated
-1.01%
IGMS - SONN
25%
Poorly correlated
+1.08%
BDRX - SONN
25%
Poorly correlated
+0.96%
ALXO - SONN
25%
Poorly correlated
+16.23%
More